Surgery may double the life expectancy for patients with kidney cancer

A new exciting medical discovery from kidney cancer patients receives the attention of international medical doctors.

Accordingly, researchers at the Mayo Clinic have just announced that surgery for patients with end-stage kidney cancer may double life expectancy.

Before, kidney cancer has increased in the United States for the past 20 years. According to information from the American Cancer Society, there are 63,990 cases diagnosed with kidney cancer and there may be 14,400 deaths in 2017.

Dr. Bradley said: "For many types of cancer, we know it will be difficult to think of long-term survival but with kidney cancer, it is a specific disease, or the patient will die sooner. because of kidney failure or will live longer than expected, this is difficult to identify in other types of cancer " - Leibovich, a Mayo urologist, said in a press release. .

Surgery may double the life expectancy for patients with kidney cancer Picture 1

This study shows that patients who have had surgery to remove secondary or metastatic kidney cancer can last 2 years to 10 years compared with non-surgical patients.

Scientists analyzed 8 previous studies on 2,267 patients with renal cell carcinoma and found average life expectancy for patients with metastatic cancer in only 8 months to 2 years, however , surgical patients can live for 3 to 12 years.

Leibovich said: "This study shows that patients who have had surgery to remove metastases, about half are likely to have died of their metastatic disease at all times after diagnosis and surgery . "

The US Food and Drug Administration approved the first drug to treat kidney cancer in 1992, but since then there have been major medical advances in drug treatment and there are more than 10 types available. Specific kidney cancer drugs.

Surgery may double the life expectancy for patients with kidney cancer Picture 2

Leibovich said the concern is because the number of drug treatments available to many patients is not constantly updated and updated to surgeons and medical oncologists globally. This causes problems in considering treatment, surgery and preventing recurrent kidney cancer.

"It is flawed if we do not get all of these drugs," Leibovich said. " Using many drugs will increase your chances of surviving treatment and surgery. And even those Drugs that work for a certain period of time may support prolonged treatment before surgery, during surgery . In general, those drugs may prolong the patient's survival . '

This research has just been published in the Journal of Urology.